Mark Hanson

Mark Hanson has had an extensive work experience in various roles and companies. Mark is currently working as the Senior Director of Strategic Business Development at Science 37, where they are responsible for global account management for AstraZeneca and GSK. Prior to this, Mark served as the Global Account Director at SAS, leading a team in industrializing AI concepts and advanced analytics for their major life sciences client. Mark also held the position of Sales Director Europe at Saama Technologies, where they played a crucial role in driving new business and establishing a European pipeline. Mark has a strong background in sales and management, having worked at Accelrys for several years in various senior positions, including Sales Director and Strategic Account Director. Mark started their career at Hickson & Welsh Limited, where they held business development and marketing management roles. Mark's experience also includes roles at Sigma Aldrich Fine Chemicals, Sigma Aldrich, and Biocatalysts Limited.

Mark Hanson completed their education in a chronological manner. Mark first attended the University of Birmingham from 1984 to 1987, where they obtained a Bachelor of Science (B.Sc) degree in Biochemistry with honors. Their field of study during this time was focused on Molecular Genetics.

Following their undergraduate studies, from 1989 to 1991, Hanson pursued a Master's in Business Administration (MBA) degree with a specialization in Strategic Market Planning at Cardiff University (also known as Prifysgol Caerdydd).

No further information regarding Mark Hanson's education history is provided.